From:  Associations between self-reported adherence to antihypertensive medications and potential mechanisms of behavior change in a general outpatient sample

 Exploratory Pearson correlations between scales with 95% confidence intervals in parentheses.

VariableHill-Bone medication adherenceHill-Bone sodiumHill-Bone missed appointmentsMASESTSRQ autonomousTSRQ controlledTSRQ amotivationSRBAIHypertension knowledgeMAR beliefs and perceptionsMAR side effects and concernsMAR practical and access barriersMAR forgetful
Hill-Bone sodium0.32** (0.13 to 0.48)------------
Hill-Bone missed appointments0.28** (0.09 to 0.45)0.03 (–0.17 to 0.22)-----------
MASES0.72*** (0.61 to 0.80)0.38*** (0.20 to 0.53)0.41*** (0.23 to 0.56)----------
TSRQ autonomous0.24* (0.05 to 0.41)0.12 (–0.08 to 0.31)0.17 (–0.03 to 0.35)0.39*** (0.21 to 0.54)---------
TSRQ controlled–0.02 (–0.21 to 0.18)–0.04 (–0.23 to 0.16)0.16 (–0.04 to 0.34)0.07 (–0.12 to 0.27)0.40*** (0.23 to 0.56)--------
TSRQ amotivation0.05 (–0.14 to 0.25)–0.02 (–0.23 to 0.16)0.11 (–0.09 to 0.30)0.10 (–0.10 to 0.29)0.03 (–0.17 to 0.22)0.62*** (0.48 to 0.72)-------
SRBAI0.17 (–0.03 to 0.35)0.09 (–0.11 to 0.28)0.09 (–0.11 to 0.28)0.19 (–0.01 to 0.37)0.28** (0.09 to 0.45)0.37*** (0.19 to 0.53)0.23* (0.03 to 0.40)------
Hypertension knowledge0.24* (0.05 to 0.42)0.16 (–0.04 to 0.34)0.06 (–0.13 to 0.26)0.16 (–0.04 to 0.34)0.08 (–0.11 to 0.27)0.09 (–0.10 to 0.28)0.05 (–0.15 to 0.24)0.06 (–0.14 to 0.25)-----
MAR beliefs and perceptions–0.20* (–0.38 to –0.01)–0.04 (–0.23 to 0.16)–0.06 (–0.26 to 0.13)–0.21* (–0.39 to –0.01)–0.04 (–0.23 to 0.16)0.16 (–0.03 to 0.35)0.17 (–0.03 to 0.35)0.01 (–0.18 to 0.21)0.10 (–0.09 to 0.29)---
MAR side effects and concerns–0.31** (–0.48 to –0.12)–0.05 (–0.25 to 0.14)–0.25* (–0.42 to –0.05)–0.48*** (–0.62 to –0.31)–0.07 (–0.26 to 0.12)0.14 (–0.05 to 0.33)0.04 (–0.16 to 0.23)0.07 (–0.13 to 0.26)–0.02 (–0.22 to 0.18)0.64*** (0.51 to 0.74)---
MAR practical and access barriers–0.21* (–0.39 to –0.01)–0.02 (–0.22 to 0.17)0.01 (–0.18 to 0.21)–0.25* (–0.42 to –0.05)–0.04 (–0.23 to 0.16)0.12 (–0.08 to 0.31)0.10 (–0.10 to 0.29)–0.05 (–0.25 to 0.14)0.02 (–0.17 to 0.22)0.88*** (0.83 to 0.92)0.67*** (0.55 to 0.76)--
MAR forgetfulness/unintentional nonadherence–0.36*** (–0.52 to –0.18)–0.22* (–0.40 to –0.02)–0.09 (–0.28 to 0.10)–0.30** (–0.47 to –0.11)–0.14 (–0.33 to 0.05)0.08 (–0.12 to 0.27)0.10 (–0.10 to 0.29)–0.12 (–0.31 to 0.08)0.00 (–0.19 to 0.20)0.67*** (0.54 to 0.76)0.54*** (0.38 to 0.66)0.68*** (0.56 to 0.77)-
MAR intentional/contextual nonadherence–0.06 (–0.26 to 0.13)0.03 (–0.17 to 0.23)0.09 (0.11 to 0.28)–0.11 (–0.30 to 0.09)–0.09 (–0.28 to 0.11)0.15 (–0.04 to 0.34)0.13 (–0.07 to 0.32)0.02 (–0.18 to 0.22)–0.03 (–0.22 to 0.17)0.76*** (0.67 to 0.83)0.46*** (0.30 to 0.60)0.80*** (0.71 to 0.86)0.61*** (0.48 to 0.72)
Return to article view

*p < 0.05; **p < 0.01; ***p < 0.001; MASES: Medication Adherence Self-Efficacy Scale; TSRQ: Treatment Self-Regulation Questionnaire; SRBAI: Self-Report Behavioral Automaticity Index; MAR: Medication Adherence Reasons. This table does not adjust for multiple comparisons and is purely exploratory. No inferences should be drawn from these findings.